Evidence map›Paper›PMID 7791762›Full record

ArticleMolecular and cellular biology1995

Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins.

L Zhu, L Zhu, E Xie, L S Chang

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
20.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 112 citations in OpenAlex.

  1. The Tumor Suppressor p53 Downregulates p107 (International journal of molecular sciences · 2025
    Article
  2. Cell Death in Chondrocytes, Osteoblasts, and Osteocytes.International journal of molecular sciences · 2016
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Visualizing dynamic E2F-mediated repression in vivo.Molecular and cellular biology · 2006
    Article
  17. Article
  18. Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

L ZhuDepartment of Pediatrics, Ohio State University, Columbus 43205, USA.
L Zhu
E Xie
L S Chang
State Library of Ohio · USNationwide Children's Hospital · US

Funding

VITAMIN E AND C--DECREASE OR INCREASE RISK OF ASTROCYTOMAP20NS031087 · NINDS · OHIO STATE UNIVERSITY · PI YATES, ALLAN JAMES · 1992 to 1994
–
FUNCTIONAL ANALYSES OF THE RETINOBLASTOMA GENE PRODUCTR29CA054323 · NCI · CHILDREN'S HOSPITAL (COLUMBUS) · PI CHANG, LONG-SHENG · 1991 to 1994
–
NCI NIH HHS CA54323NINDS NIH HHS NS31087
6 · The paper itself

Abstract

Although many lines of evidence indicate that the cellular protein p107 is closely related to the retinoblastoma protein, the exact function of the p107 gene and its regulation are presently not known. To investigate the molecular mechanism controlling expression of the human p107 gene, a 5' flanking sequence of this gene was isolated and shown to promote high-level expression of a luciferase reporter gene in cycling human 293 and Saos-2 cells. Sequencing and transcription mapping analyses showed that the human p107 promoter is TATA-less and contains a tandem, direct repeat of E2F-binding sites, with the 3' copy overlapping the major transcription initiation site. Deletion analysis of the p107 promoter showed that a promoter DNA fragment containing only the two E2F sites together with the leader sequence could direct relatively efficient expression in 293 cells. Site-directed mutagenesis of these E2F sites revealed that although both sites were important for p107 promoter activity, mutation on the proximal, initiation site copy of the E2F site showed a stronger effect. The human p107 promoter could be repressed by the retinoblastoma protein and its own gene product. Interestingly, the repression was found to be mediated through the 5' copy of the E2F site. These studies demonstrate for the first time differential roles of two tandem E2F sites in promoter regulation.

Indexed as

Carrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsGene Expression Regulation, NeoplasticBase SequenceBinding SitesCloning, MolecularDNA Mutational AnalysisE2F Transcription FactorsGenes, ReporterHumansMolecular Sequence DataNuclear ProteinsPromoter Regions, GeneticProtein BindingRecombinant Fusion ProteinsCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsE2F Transcription FactorsNuclear ProteinsRBL1 protein, humanRecombinant Fusion ProteinsRetinoblastoma-Binding Protein 1Retinoblastoma-Like Protein p107Retinoblastoma ProteinTranscription Factor DP1Transcription Factors

Identifiers

PMID7791762
PMCPMC230592
OpenAlexW2114527659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.